Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study.
Reinders MEJ, Groeneweg KE, Hendriks SH, Bank JR, Dreyer GJ, de Vries APJ, van Pel M, Roelofs H, Huurman VAL, Meij P, Moes DJAR, Fibbe WE, Claas FHJ, Roelen DL, van Kooten C, Kers J, Heidt S, Rabelink TJ, de Fijter JW. Reinders MEJ, et al. Among authors: moes djar. Am J Transplant. 2021 Sep;21(9):3055-3065. doi: 10.1111/ajt.16528. Epub 2021 Mar 18. Am J Transplant. 2021. PMID: 33565206 Free PMC article. Clinical Trial.
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.
Meziyerh S, Zwart TC, van Etten RW, Janson JA, van Gelder T, Alwayn IPJ, de Fijter JW, Reinders MEJ, Moes DJAR, de Vries APJ. Meziyerh S, et al. Among authors: moes djar. Am J Transplant. 2020 Jul;20(7):1896-1901. doi: 10.1111/ajt.15943. Epub 2020 May 13. Am J Transplant. 2020. PMID: 32337790 Free PMC article.
Response: Limited sampling strategies for once daily tacrolimus exposure monitoring.
Moes DJ, Swen JJ, van der Bent SA, van der Straaten T, Inderson A, Olofsen E, Verspaget HW, Guchelaar HJ, den Hartigh J, van Hoek B. Moes DJ, et al. Eur J Clin Pharmacol. 2016 Jun;72(6):775-6. doi: 10.1007/s00228-016-2036-y. Epub 2016 Mar 2. Eur J Clin Pharmacol. 2016. PMID: 26931555 No abstract available.
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft.
Loeff FC, van Egmond EHM, Moes DJAR, Wijnands C, Von Dem Borne PA, Veelken H, Falkenburg JHF, Jedema I, Halkes CJM. Loeff FC, et al. Among authors: moes djar. Transpl Immunol. 2019 Dec;57:101209. doi: 10.1016/j.trim.2019.06.001. Epub 2019 Jun 14. Transpl Immunol. 2019. PMID: 31207283 Free article.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: moes djar. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.
109 results